Shawn Xiong

Xiaomo (Shawn) Xiong, Ph.D., is an Assistant Professor the Division of Pharmacy Practice and Administrative Sciences at the University of Cincinnati College of Pharmacy. His primary research interests include health outcomes research using real-world data and pharmacoeconomic modeling. He is highly experienced in working on different types of real-world data, including claims data, survey data, and electronic health records data. In addition, he has vast pharmacoeconomic modeling experience using Microsoft Excel, R, and TreeAge in studying a wide range of diseases, including cancer, rheumatoid arthritis, and Alzheimer's disease.

Pharmacoeconomics, econoimc modeling, comparative effectiveness, health outcomes, real-world evidence, real-world study, machine learning.

Grant: #P30AG034532 Investigators:Xiong, Xiaomo 06-01-2025 -05-31-2026 National Institute on Aging (Subaward through NBER) Effect of Insurance Plans on Health Behavior, Health Services Utilization, and Costs in Disadvantaged and Vulnerable Individuals with ADRD Role:PI $25,000.00 Active

Investigators:Guo, Jianfei (Jeff); Xiong, Xiaomo -11-30-2027 National Institute on Aging GLP-1 Agonists for Preventing Alzheimer's Disease in Mild Cognitive Impairment Role:PI 0.00

Grant: #UCCC Pilot Award Investigators:Xiong, Xiaomo 05-15-2025 -05-14-2026 University of Cincinnati Cancer Center Determinants of Delay in EGFR Inhibitor Initiation and Its Impact Role:PI $50,000 Active Type:Grant Level:University

Peer Reviewed Publications

Xiong, Xiaomo; Chen, Zhanghe; Yan, Bingfang (2026. ) Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database.Therapeutic advances in drug safety, , 17 ,20420986251396038 More Information

Jiang, Xiangxiang; Lv, Gang; Xiong, Xiaomo; Li, Minghui; Yuan, Jing; Lu, Z Kevin (2025. ) Cannabis Use, Disorders, and Disparities Under the Controlled Substances Act: NSDUH 2015-2019.Journal of general internal medicine, , 40 (9 ) ,2143-2146 More Information

Lv, Gang; Chinaeke, Eric; Jiang, Xiangxiang; Xiong, Xiaomo; Wu, Jun; Yuan, Jing; Lu, Z Kevin (2025. ) Economic outcomes of diabetes self-management education among older Medicare beneficiaries with diabetes.BMC health services research, , 25 (1 ) ,686 More Information

Xiong, Xiaomo; Lv, Gang; King, Jacob Jordan; Li, Minghui; Yuan, Jing; Lu, Z Kevin (2025. ) Cost-effectiveness analysis of aducanumab versus placebo for patients with mild cognitive impairment and mild Alzheimer's disease.BMJ open, , 15 (4 ) ,e090403 More Information

DiBello, Julia R; Xiong, Xiaomo; Liu, Xinyue; Zhong, Wenjun; Merola, Aristide; Li, Minghui; Lu, Z Kevin (2025. ) Trajectories of pharmacological therapies for treatment-resistant depression: a longitudinal study.BMC psychiatry, , 25 (1 ) ,215 More Information

Xiong, Xiaomo; Guo, Jeff Jianfei (2025. ) Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA.PharmacoEconomics, , 43 (3 ) ,271-282 More Information

Yuan, Jing; Lu, Z Kevin; Xiong, Xiaomo; Li, Minghui; Liu, Yang; Wang, Long-De; Liu, Renyu; Zhao, Jing (2023. ) Age and geographic disparities in acute ischaemic stroke prehospital delays in China: a cross-sectional study using national stroke registry data.The Lancet regional health. Western Pacific, , 33 ,100693 More Information

Lu, Kevin; Xiong, Xiaomo; Li, Minghui; Yuan, Jing; Luo, Ye; Friedman, Daniela B (2022. ) Trends in prevalence, health disparities, and early detection of dementia: A 10-year nationally representative serial cross-sectional and cohort study.Frontiers in public health, , 10 ,1021010 More Information

Yuan, Jing; Lu, Z Kevin; Xiong, Xiaomo; Lee, Tai-Ying; Huang, Huang; Jiang, Bin (2022. ) Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus.Frontiers in pharmacology, , 13 ,842944 More Information

Xiong, Xiaomo; Jiang, Xiangxiang; Lv, Gang; Yuan, Jing; Li, Minghui; Lu, Z Kevin (2022. ) Evidence of Chinese Herbal Medicine Use From an Economic Perspective: A Systematic Review of Pharmacoeconomics Studies Over Two Decades.Frontiers in pharmacology, , 13 ,765226 More Information

Lu, Kevin; Xiong, Xiaomo; Horras, Ashley; Jiang, Bin; Li, Minghui (2022. ) Impact of financial barriers on health status, healthcare utilisation and economic burden among individuals with cognitive impairment: a national cross-sectional survey.BMJ open, , 12 (5 ) ,e056466 More Information

Yuan, Jing; Li, Minghui; Liu, Yang; Xiong, Xiaomo; Zhu, Zhengbao; Liu, Fangyu; Wang, Yong; Hu, Wei; Lu, Z Kevin; Liu, Renyu; Zhao, Jing (2022. ) Analysis of Time to the Hospital and Ambulance Use Following a Stroke Community Education Intervention in China.JAMA network open, , 5 (5 ) ,e2212674 More Information

Lu, Z Kevin; Xiong, Xiaomo; Lee, Taiying; Wu, Jun; Yuan, Jing; Jiang, Bin (2021. ) Corrigendum: Big Data and Real-World Data Based Cost-Effectiveness Studies and Decision-Making Models: A Systematic Review and Analysis.Frontiers in pharmacology, , 12 ,833827 More Information

Alnijadi, Abdulrahman A; Li, Minghui; Wu, Jun; Xiong, Xiaomo; Lu, Z Kevin (2022. ) Trend and effects of high-deductible health insurance plans in the health care system: financial access problems in management of cognitive impairment.Journal of managed care & specialty pharmacy, , 28 (1 ) ,7-15 More Information

Lu, Z Kevin; Xiong, Xiaomo; Lee, Taiying; Wu, Jun; Yuan, Jing; Jiang, Bin (2021. ) Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis.Frontiers in pharmacology, , 12 ,700012 More Information

Yuan, Jing; Lu, Z Kevin; Xiong, Xiaomo; Jiang, Bin (2021. ) Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China.BMJ global health, , 6 (9 ) , More Information

Lu, Z Kevin; Xiong, Xiaomo; Wang, Xinyuan; Wu, Jun (2021. ) Gender Disparities in Anti-dementia Medication Use among Older Adults: Health Equity Considerations and Management of Alzheimer's Disease and Related Dementias.Frontiers in pharmacology, , 12 ,706762 More Information

Xiong, Xiaomo; Yuan, Jing; Li, Minghui; Jiang, Bin; Lu, Z Kevin (2021. ) Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management.Frontiers in medicine, , 8 ,700014 More Information

Lu, Z Kevin; Xiong, Xiaomo; Brown, Jacob; Horras, Ashley; Yuan, Jing; Li, Minghui (2021. ) Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare.Frontiers in pharmacology, , 12 ,706289 More Information

Zhang, Weiwei; Lv, Gang; Xiong, Xiaomo; Li, Minghui (2021. ) Effect of Cost-Related Medication Non-adherence Among Older Adults With Medication Therapy Management.Frontiers in medicine, , 8 ,670034 More Information

Lv, Gang; Yuan, Jing; Xiong, Xiaomo; Li, Minghui (2021. ) Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination.Frontiers in medicine, , 8 ,670370 More Information

Yan, Bohua; Jiang, Zhiwei; Yuan, Jing; Li, Minghui; Zeng, Jieping; Tang, Jianyuan; Lu, Z Kevin; Ding, Hong; Xia, Jielai; Wang, Qiaoling; Wang, Jundong; Xie, Hongyan; Li, Wenyuan; Zhang, Na; Li, Haiyan; Sang, Xiaoya; Wu, Lina; Xiong, Xiaomo; Tang, Shiyun; Li, Yan; Tao, Mengyao; Xie, Chunguang; Yu, Shuguang (2021. ) Effects and safety of herbal medicines among community-dwelling residents during COVID-19 pandemic: A large prospective, randomized controlled trial (RCT).Phytomedicine : international journal of phytotherapy and phytopharmacology, , 85 ,153403 More Information

Guan, Xin; Li, Hongchao; Xiong, Xiaomo; Peng, Cike; Wang, Ning; Ma, Xiao; Ma, Aixia (2021. ) Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China.Journal of medical economics, , 24 (1 ) ,339-344 More Information

Tian, Lei; Xiong, Xiaomo; Guo, Qiang; Chen, Yixi; Wang, Luying; Dong, Peng; Ma, Aixia (2020. ) Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China.PharmacoEconomics, , 38 (12 ) ,1345-1358 More Information

Zhou, Ting; Guan, Haijing; Yao, Jiaqi; Xiong, Xiaomo; Ma, Aixia (2018. ) The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, , 27 (11 ) ,2799-2814 More Information